A tailored course, built for your situation
Mastering FDA 21 CFR Part 11 for Senior Principal Scientists in Biopharma Development
Turn regulated documentation requirements into strategic advantage through precise, auditable execution.
$199 one-time
24-hour access provisioning
30-day money-back guarantee
Hand-built implementation playbook
12 modules. 12 chapters per module. 144 chapters total.
12 modules, each with 12 chapters (144 chapters total), text-based, plus downloadable templates and a hand-built implementation playbook delivered alongside course access.
High-stakes data work that never reaches decision-makers
The situation this course is for
Critical scientific documentation gets buried in technical detail, failing to reach executives who rely on clean, auditable trails. Work is correct but invisible.
Who this is for
Senior Principal Scientist in biopharmaceutical R&D, leading pre-clinical programs with accountability for data integrity and regulatory readiness.
Who this is not for
Entry-level lab technicians, non-regulated industry scientists, or professionals without direct responsibility for audit-ready documentation.
What you walk away with
- Produce documentation artefacts that clearly demonstrate compliance with FDA 21 CFR Part 11 by design
- Structure experimental workflows to meet electronic records and signatures requirements without rework
- Anticipate auditor and regulator scrutiny with pre-validated templates and traceability matrices
- Demonstrate control and consistency in a way that surfaces your work to senior scientific leadership
- Integrate compliance thinking early so it accelerates rather than interrupts development timelines
The 12 modules (with all 144 chapters)
Module 1. Understanding FDA 21 CFR Part 11 Scope and Intent
Clarify which systems and processes fall under regulation. Learn to distinguish between covered and exempt activities in biopharma R&D environments.
12 chapters in this module
- Overview of electronic records and signatures
- Key terms in Part 11
- Applicability in pre-clinical research
- Regulatory interpretation trends
- Systems requiring validation
- Exemptions and exclusions
- Internal classification framework
- Boundary mapping exercise
- Documentation scope checklist
- Integration with GLP workflows
- Common misapplications
- Module recap and next steps
Module 2. Validating Electronic Systems for Regulated Use
Build confidence in your lab software and data tools through a repeatable validation process aligned with Part 11 expectations.
12 chapters in this module
- Validation lifecycle phases
- Defining system boundaries
- User requirements specification
- Risk-based validation approach
- Test script development
- IQ OQ PQ fundamentals
- Cloud-based system validation
- Vendor documentation review
- Change control integration
- Validation status reporting
- Periodic review schedule
- Template adaptation guide
Module 3. Audit Trail Design for Scientific Workflows
Implement tamper-evident, time-stamped audit trails that survive inspection and reinforce credibility.
12 chapters in this module
- Audit trail requirements in Part 11
- Types of audit-relevant actions
- Data creation and modification
- User login and logout tracking
- System-generated timestamps
- Ensuring data integrity
- Protecting audit logs
- Access controls for logs
- Review frequency standards
- Integration with LIMS
- Troubleshooting gaps
- Audit-ready documentation
Module 4. Electronic Signatures in Regulated Environments
Apply multi-factor electronic signatures correctly and consistently across documentation and reports.
12 chapters in this module
- Part 11 electronic signature criteria
- Signature manifestation types
- Identity verification methods
- Signature linkage to records
- Two-person rule scenarios
- Signature repeatability
- System configuration
- Signature training requirements
- Revocation procedures
- Signature audit trail
- Common implementation errors
- Gap analysis worksheet
Module 5. Data Integrity Principles for GxP Work
Embed ALCOA+ principles into daily practice to meet FDA expectations for reliable scientific data.
12 chapters in this module
- What ALCOA+ means in practice
- Attributable data standards
- Legibility over time
- Contemporaneous recording
- Original data capture
- Accuracy checks
- Complete records
- Consistent application
- Enduring data storage
- Available access protocols
- Data governance roles
- Self-assessment tool
Module 6. Document Control Under Part 11
Manage SOPs, protocols, and reports with version control that satisfies regulator scrutiny.
12 chapters in this module
- Electronic document lifecycle
- Version numbering scheme
- Approval workflows
- Access permissions setup
- Change tracking
- Review cycle automation
- Retention requirements
- Retirement process
- Cross-reference mapping
- Integration with QMS
- Exception handling
- Compliance monitoring
Module 7. Risk Assessment for Part 11 Compliance
Prioritize efforts using a structured, defensible risk model tailored to development-stage biopharma.
12 chapters in this module
- Risk assessment methodology
- Identifying critical systems
- Data criticality scoring
- Process failure impact
- Likelihood estimation
- Risk ranking matrix
- Mitigation planning
- Control validation
- Residual risk reporting
- Stakeholder alignment
- Documentation format
- Audit preparation
Module 8. Part 11 Compliance in Pre-Clinical Development
Adapt requirements to early-stage research where flexibility and innovation coexist with compliance.
12 chapters in this module
- Regulatory expectations in discovery
- Balancing agility and control
- Data handling in animal studies
- Electronic lab notebook use
- Instrument data capture
- Raw data storage
- Protocol deviation tracking
- SOP applicability
- Training documentation
- Study report integrity
- Cross-phase consistency
- Institutional review board interface
Module 9. Preparing for FDA Inspections
Turn inspection readiness from reactive scramble to built-in capability.
12 chapters in this module
- Common inspection focus areas
- Document retrieval speed
- Staff interview preparation
- Audit trail demonstration
- Electronic signature walkthrough
- Data integrity evidence
- Deficiency response process
- Mock inspection design
- Corrective action planning
- Communication protocols
- Post-inspection reporting
- Lessons from past 483s
Module 10. Change Control and Lifecycle Management
Manage system and process changes without compromising compliance status.
12 chapters in this module
- Types of changes
- Impact assessment
- Approval authority matrix
- Testing after change
- Documentation updates
- Version rollback plan
- Incident linkage
- Vendor change notifications
- Regulatory reporting triggers
- Change log maintenance
- Review cadence
- Automation tools
Module 11. Training and Compliance Culture
Scale understanding across teams so compliance becomes second nature.
12 chapters in this module
- Role-based training needs
- Initial and refresher training
- Electronic training records
- Competency assessment
- Supervisor responsibilities
- Onboarding integration
- Training audit trail
- Policy attestation
- Knowledge retention
- Feedback collection
- Culture measurement
- Improvement roadmap
Module 12. Strategic Integration of Part 11 Across Development
Position your compliance work as an enabler of speed and trust across the organization.
12 chapters in this module
- Linking compliance to speed
- Reducing audit delays
- Facilitating tech transfer
- Supporting regulatory submissions
- Cross-functional alignment
- Executive communication
- Metrics that matter
- Showcasing value
- Future-proofing design
- Continuous improvement
- Scaling lessons
- Course completion and next steps
How this maps to your situation
- When starting a new pre-clinical study
- During technology platform implementation
- Ahead of internal audit or FDA inspection
- While scaling documentation processes for regulatory submission
Before vs. after
Before
Critical scientific work meets compliance standards but remains unseen by leadership.
After
Your documentation and processes naturally surface due to clarity, traceability, and audit readiness.
What's included with your purchase
- 12 modules with 12 chapters each (144 chapters)
- Downloadable templates and worked examples for every module
- Hand-built implementation playbook delivered alongside course access
- 30-day money-back guarantee
Delivery and format
- Course and learning environment access provisioned within 24 hours of purchase
- Hand-built implementation playbook delivered alongside course access
Format: Text-based modules and chapters in the Art of Service learning environment, plus downloadable templates and worked examples for every chapter, plus the hand-built implementation playbook delivered alongside course access.
Time investment: Approximately 3 hours per module, designed to be completed at your pace over 6, 8 weeks.
If nothing changes
Continuing with invisible compliance increases the chance that your contributions are overlooked during advancement discussions, even when technically flawless.
How this compares to the alternatives
Generic GxP courses cover broad principles but lack precision on FDA 21 CFR Part 11 application in active pre-clinical development. This course is tailored to scientists who must document electronic records and signatures correctly the first time.
Frequently asked
Who is this course for?
Senior Principal Scientists and team leads in biopharma R&D with accountability for data integrity and regulatory documentation under FDA oversight.
How is the course structured?
12 modules, each containing 12 chapters (144 chapters total).
Does this cover EU GMP or only FDA?
The course focuses on FDA 21 CFR Part 11, but principles align with Annex 11 and support global readiness.
$199 one-time. Approximately 3 hours per module, designed to be completed at your pace over 6, 8 weeks..
Within 24 hours your account in the learning environment is provisioned and the tailored implementation playbook is delivered alongside it.
30-day money-back guarantee·
144 chapters·
Hand-built playbook included·
Account access within 24 hours